COMBINATION OF CIS-4-HYDROXY-L-PROLINE AND N-METHYL-CIS-4-HYDROXY-L-PROLINE FOR USE AS A THERAPEUTIC AGENT, IN PARTICULAR IN CANCER TREATMENT

摘要

The disclosure relates to a combination of cis-4-hydroxy-L-proline and n-methyl-cis-4-hydroxy-l-proline for use as a therapeutic agent, in particularin cancer treatment. Also disclosed is the use of the individual substancesfor treating hormone-sensitive prostate cancer.